Conversely, as kidney function declines, retention of uraemic toxins, oxidative stress, and renin–angiotensin–aldosterone activation aggravate insulin resistance, dyslipidemia, and systemic inflammation, worsening hepatic steatosis and promoting fibrogenesis [18]. This evidence concerns the gene REN and fatty liver disease.